In the future it will be common practice to use stem cell products to treat illnesses in the same way we use medications today
Pipeline
- ADSC for the treatment of Multiple Sclerosis (MS)
- Anti-BMP small molecules for the treatment of MS
- Genetically modified muscle progenitor cells (MPCs) that secrete neurotropic factors (NTFs)
- MPC-NTFs: peripheral nerve injury
- MPC-NTFs: neuropathic pain
- Mesenchymal stem cell derived vesicles – exosomes secreted from cells for the treatment of autistic disorders
- Production and Supply of Finolim (Fingolimod, Gilenia™)
- Adipose-derived stem cell (ADSC) secreted factors: cosmetic products